28-Oct-2026 17:05:30
SUDEEPPHRMGeneral news
SUDEEPPHRM Q2 : CONS NET PROFIT UP 12.5% AT RS 51.45 CR (YOY), UP 26.9% (QOQ)
• Revenue up 20.9% at ₹196.70 Cr (YOY), up 24.3% (QOQ). • Ebitda ex-other income up 32.0% at ₹73.24 Cr (YOY), up 33.4% (QOQ); margins 37.2% v 34.1% (YOY), 34.7% (QOQ). • Pharma, food and nutrition revenue up 57.5% at ₹142.50 Cr (YOY); specialty ingredients down 24.9% at ₹54.20 Cr (YOY). • H1 revenue up 23.4% at ₹354.97 Cr; H1 profit after tax up 18.4% at ₹92.40 Cr.
Sudeep Pharma Ltd
Open attachment